StockWatch
·

National Peroxide Ltd Q2 FY27 Results

NPLQ2 FY27 Results
Filing
Result:Weak· Market: Down#Base effect#Margin squeeze
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue112.0416.6%64.1%
Total Income113.8415.9%62.7%
Expenditure112.6826.1%62.5%
PBT1.1686.8%83.5%
Net Profit0.8786.8%125.6%
OPM4.46%8.28pp2.13pp
NPM0.76%5.97pp0.21pp
EPS1.5186.9%125.4%
View full financials

Chemicals sector key metrics—OPM and EBITDA margin—nearly halved YoY (4.46% vs 6.59%) and collapsed sequentially from 12.74%, with the PAT YoY gain just a tiny-base effect that masks deteriorating core operating profitability.

Q2 FY-2027 RESULTS · NPL

National Peroxide Q2FY27: revenue +64% YoY, but margin collapse sinks PAT 87% QoQ

PAT +125.6% YoY · revenue +64.07% · margins compressing

11 Nov 2026 · 3 min read
Revenue

₹112.04 Cr

+64.07% YoY

PAT (standalone)

₹0.87 Cr

+125.6% YoY

Net margin

0.76%

+0.2pp YoY

EPS

₹1.51

National Peroxide's standalone revenue rose 64.1% YoY to ₹112.04 Cr (and +16.6% QoQ from ₹96.07 Cr in Q1FY27), but profit after tax of just ₹0.87 Cr tells a much weaker story than the topline suggests. PAT is up nominally from a thin ₹0.39 Cr a year ago, but that YoY comparison is off a near-zero base and is dwarfed by the sequential collapse — PAT fell 86.8% quarter-on-quarter from ₹6.61 Cr in Q1FY27, even as revenue grew. There were no exceptional items in either the current or year-ago quarter, so this is a clean, like-for-like comparison, not a one-off distortion.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹112.04 Cr+16.6%+64.1%
Expenses₹112.68 Cr+26.1%+62.6%
PAT₹0.87 Cr-86.83%+125.6%
Net margin0.76%-6pp+0.2pp
EPS₹1.51-86.9%+125.4%

The real story is margin compression on the operating line: OPM nearly halved to 4.46% from 6.59% a year ago, and fell sharply from 12.74% in Q1FY27 — cost of raw materials and packing materials consumed rose to ₹59.47 Cr from ₹52.99 Cr sequentially, outpacing the revenue increase. Net margin actually ticked up YoY (0.78% vs 0.55%) only because lower finance costs (₹0.24 Cr vs ₹0.35 Cr) cushioned the thin operating profit against last year's even thinner base — it still fell steeply from 6.73% in Q1FY27. Effective tax rate was ~25.2%, unremarkable.

₹
462.01520.89579.78638.66697.5454308-1009-0109-2410-1911-11Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹543, down 7.4% over the past month of trading.

₹ Cr
02.965.928.880.89Q1 FY26rev ₹67 Cr0.39Q2 FY26rev ₹68 Cr1.83Q3 FY26rev ₹69 Cr7.93Q4 FY26rev ₹86 Cr6.61Q1 FY27rev ₹96 Cr0.87Q2 FY27rev ₹112 Cr
Quarterly standalone PAT, ₹ Crore

There is no management guidance or prior concall commentary on record to grade this print against, and no formal management press release accompanied this filing beyond the routine board-outcome letter — management gives no outlook to assess met/missed. No analyst previews or consensus estimates for this quarter turned up in a search, consistent with this being a thinly covered micro-cap (vsStreet unknown). The results coincide with corporate change: Vinay Jayade, appointed CEO effective October 1, 2026 after Rajiv Arora's resignation, signed this result as CEO & Director, and the board separately approved Amit Shah as Head–Sales & Marketing the same day — neither development has numbers attached yet but both land right as the cost base is under pressure.

  • W1

    Whether OPM recovers toward the 12.74% seen in Q1FY27 or stays compressed near the current 4.46% — no cost-driver commentary accompanied this filing

  • W2

    Execution under new CEO Vinay Jayade and new sales head Amit Shah in the next 1-2 quarters

  • W3

    Raw material cost trajectory — consumption cost rose to ₹59.47 Cr this quarter from ₹52.99 Cr in Q1FY27, a faster pace than revenue growth

Standalone-only filing (no consolidated section); raw PDF text-extraction scrambled the table's column order but every cross-check (Total Income, Total Expenses, HY=Q1+Q2, PBT-tax=PAT) ties out exactly against the given column headers, so figures are reliable. A ₹0.58 Cr exceptional item appears only in the FY26 annual column, not in either quarter being compared, so YoY/QoQ are like-for-like.

Informational and educational content only. Not investment advice.